rs230534

This variant is located in the NFKB1 gene.

GWAS Catalog Trait Associations (2)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

primary biliary cirrhosis

Allele T
OR 0.31
p 5.0e-15
N 6,778
Meta-analysis
East Asian

systemic scleroderma

Allele T
OR 0.06
p 4.0e-12
N 140,706
Large GWAS
multi-ancestry
Allele T
OR 1.15
p 5.0e-9
N 26,679
Large GWAS
European

Research that mentions this SNP (3)

Brief Report: Candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity
ReviewEugénie Koumakis et al.(2012)· Arthritis &amp; Rheumatism

This review article by Ota and Kuwana synthesizes genetic studies on systemic sclerosis (SSc), a complex autoimmune disease. Multiple genetic association studies, including GWAS and candidate gene approaches, have identified SSc susceptibility genes primarily involved in innate immunity (IRF4, IRF5, IRF7, IRF8, TNFAIP3), adaptive immune response (TNFSF4, CD247, PTPN22, CSK, STAT4, BLK), IL-12 signaling (IL-12A, IL-12RB1, IL-12RB2, TYK2), apoptosis/autophagy (ATG5, GSDMA, GSDMB, NOTCH4), and vascular homeostasis/fibrosis (PPARG). The review emphasizes that identified risk variants are predominantly located in non-coding regulatory regions and influence gene expression rather than protein structure.

Traits studied:Anti-PM-SclAnti-RNA polymerase IIIAnti-U1RNPAnti-topoisomerase I (anti-topo I)Anticentromere antibody (ACA)Diffuse cutaneous SSc (dcSSc)Interstitial lung disease (ILD)Limited cutaneous SSc (lcSSc)Raynaud's phenomenonSSc-related autoantibodiesSystemic sclerosis (SSc)
Association of the FAM167A–BLK region with systemic sclerosis
ReviewIkue Ito et al.(2010)· Arthritis &amp; Rheumatism

This is a comprehensive review of genetic factors in systemic sclerosis (SSc), a complex autoimmune disease. The review synthesizes findings from candidate gene analysis and genome-wide association studies identifying numerous SNPs and genetic variants associated with SSc susceptibility, primarily in genes involved in innate immunity (IRF4, IRF5, IRF7, IRF8, TNFAIP3), adaptive immunity (TNFSF4, PTPN22, STAT4, BLK, PRDM1), and cell death pathways (ATG5, DNASE1L3, GSDMA/B, NOTCH4). HLA class II genes are associated with SSc-related autoantibodies rather than SSc itself, with DRB1 alleles carrying the FLEDR amino acid sequence critical for anti-topo I antibody responses.

Traits studied:Anti-PM-Scl antibodyAnti-RNA polymerase III antibodyAnti-U1RNP antibodyAnti-centromere antibodyAnti-topoisomerase I antibodyDiffuse cutaneous systemic sclerosisLimited cutaneous systemic sclerosisSSc-related interstitial lung diseaseSystemic sclerosis
Association of a KCNA5 gene polymorphism with systemic sclerosis–associated pulmonary arterial hypertension in the European Caucasian population
ReviewWipff J. et al.(2010)· Arthritis &amp; Rheumatism

This review updates knowledge on genetic factors in systemic sclerosis (SSc) susceptibility and disease expression. GWAS and candidate gene studies have identified multiple SSc-associated genetic variants primarily located in non-coding regions that influence gene expression through eQTL effects. Major risk genes include those involved in innate immunity (IRF4, IRF5, IRF7, IRF8, TNFAIP3), adaptive immune response (PTPN22, STAT4, TNFSF4, CD247), and cell death pathways (ATG5), while few genes directly involve fibrosis or vascular homeostasis. HLA class II genes associate with SSc-related autoantibodies rather than SSc itself. Multi-omics approaches are needed to characterize the complex molecular architecture and identify biomarkers.

Traits studied:Anti-topoisomerase I antibodiesAnticentromere antibodiesDiffuse cutaneous systemic sclerosisInterstitial lung diseaseLimited cutaneous systemic sclerosisPulmonary fibrosisSSc-related autoantibodiesSystemic sclerosis

About NFKB1

This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]

View all NFKB1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…